Why Need to Watch: Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR), Brookdale Senior Living (NYSE:BKD), CASI Pharmaceuticals (NASDAQ:CASI), The GEO Group (NYSE:GEO), Roper Technologies (NYSE:ROP)

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) today announced that William (Bill) Merino has been retained as a senior clinical and regulatory advisor to the company. Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) belongs to Healthcare sector. Its weekly performance is -10.25%. On last trading day company shares ended up $3.59. Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) distance from 50-day simple moving average (SMA50) is -13.05%.

On 3 August, Brookdale Senior Living Inc (NYSE:BKD) reported financial and operating results for the second quarter of 2015. The company announced earnings per share of $-0.46 against a consensus Street estimate of $0.64, missing estimate by $1.1. This corresponds to an increase of $0.57 compared to the same quarter of the previous fiscal year. Brookdale Senior Living Inc. (NYSE:BKD) shares decreased -1.73% in last trading session and ended the day at $30.13. BKD Gross Margin is 29.30% and its return on assets is -3.00%. Brookdale Senior Living Inc. (NYSE:BKD) quarterly performance is -15.29%.

On 22 July, CASI Pharmaceuticals, Inc. (NASDAQ:CASI) has launched Zevalin in Hong Kong to treat non-Hodgkin’s lymphoma (NHL). On 05 August, CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shares decreased -1.29% and was closed at $1.53. CASI EPS growth in last 5 year was 4.50%. CASI Pharmaceuticals, Inc. (NASDAQ:CASI) year to date (YTD) performance is 15.04%.

The GEO Group, Inc. (NYSE:GEO) reported that on July 31, 2015, its Board of Directors reported a quarterly cash dividend of $0.62 per share. The quarterly cash dividend will be paid on August 24, 2015 to shareholders of record as of the close of business on August 14, 2015. The GEO Group, Inc. (NYSE:GEO) ended the last trading day at $34.90. Company weekly volatility is calculated as 2.92% and price to cash ratio as 37.76. The GEO Group, Inc. (NYSE:GEO) showed a weekly performance of -7.25%.

On 27 July, Roper Technologies Inc. (NYSE:ROP) reported second quarter adjusted EPS of $1.70 Monday morning, compared to $1.56 a year ago. Adjusted revenue was $892 million. The consensus estimates were for EPS of $1.64 and revenues of $908.24 million. Roper Technologies, Inc. (NYSE:ROP) shares moved up 0.39% in last trading session and ended the day at $167.39. ROP Gross Margin is 59.70% and its return on assets is 7.70%. Roper Technologies, Inc. (NYSE:ROP) quarterly performance is -0.41%.

Leave a Reply

Your email address will not be published. Required fields are marked *